Abstract Objective: To determine the value of procalcitonin (PCT) in the early diagnosis (and differentiation) of patients with SIRS, sepsis, severe sepsis, and septic shock in comparison to C-reactive protein (CRP), white blood cell and thrombocyte count, and APACHE-II score (AP-II). Design: Prospective cohort study including all consecutive patients admitted to the ICU with the suspected diagnosis of infection over a 7-month period. Patients and methods: A total of 185 patients were included: 17 patients with SIRS, 61 with sepsis, 68 with severe sepsis, and 39 patients with septic shock. CRP, cell counts, AP-II and PCT were evaluated on the first day after onset of inflammatory symptoms. Results: PCT values were highest in patients with septic shock (12.89 4.39 ng/ml; P < 0.05 vs patients with severe sepsis). Patients with severe sepsis had significantly higher PCT levels than patients with sepsis or SIRS (6.91 3.87 ng/ml vs 0.53 2.9 ng/ml; P < 0.001, and 0.41 3.04 ng/ml; P < 0.001, respectively). AP-II scores did not differ significantly between sepsis, severe sepsis and SIRS (19.26 1.62, 16.09 2.06, and 17.42 1.72 points, respectively), but was significantly higher in patients with septic shock (29.27 1.35, P < 0.001 vs patients with severe sepsis). Neither CRP, cell counts, nor the degree of fever showed significant differences between sepsis and severe sepsis, whereas white blood cell count and platelet count differed significantly between severe sepsis and septic shock. Conclusions: In contrast to AP-II, PCT appears to be a useful early marker to discriminate between sepsis and severe sepsis. [3, 4, 5, 6] or localized infection. The aim of the present prospective study was to evaluate the value of PCT as an early marker for diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock in a cohort of medical ICU patients.
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Patients and methods
Between the 1st September 1997 and the 31st March 1998, all consecutive patients admitted to the internal/neurological ICU (intensive care unit) of a 1770-bed hospital in central Berlin (Krankenhaus Neukölln) with the suspected diagnosis of infection were included in this prospective cohort study (185 of 1114 patients). Body temperature, white blood cell count, platelet count, CRP, AP-II, and PCT were determined during the first 24 h after admission. Retrospectively, after analysis of all diagnostic criteria, patients were categorized with the help of the criteria of the consensus conference of the American College of Chest Physicians/Society of Critical Care Medicine [7] . Diagnosis distributed as follows: SIRS (n = 17), sepsis (n = 61), severe sepsis (n = 68), septic shock (n = 39).
PCT was determined with an immunoluminometric assay (B. R. A. H. M.S. Diagnostica, Berlin, Germany). The test needs 2±3 h and 20 ml of serum or plasma. Inter-assay and intra-assay variation at high and low concentrations is < 8 % and 7 % respectively. The upper normal limit is 0.5 ng/ml. CRP was determined by nephelometry (Behringwerke, Marburg, Germany). The upper normal limit is 0.5 mg/dl. Both parameters are routinely tested in the central laboratory of our hospital.
Data are expressed as mean SD. To examine differences between patient groups the values were adjusted for multiplicity by the method according to Bonferroni-Holm and the Wilcoxon test for unpaired samples. The ability of PCT to predict severe sepsis or septic shock was evaluated performing ROC analyses to compare PCT in SIRS/sepsis vs severe sepsis/septic shock patients and further, to compare PCT in severe sepsis vs septic shock patients. Cutoff points were determined as to maximize the accuracy (percentage of correctly predicted patients) of classification via PCT. Sensitivity, specificity and ROC diagrams are given according to the usual definitions. Positive and negative predictive values are calculated using the observed population prevalence of the diagnoses. They should be generalized to populations with comparable prevalences.
Results 185 patients, of whom 130 (70.2 %) needed mechanical ventilation, were included in the analysis. The mean age was 59.8 15.3 years (median 63, range 14±86). Total mortality was 28.1 % (52 patients). In detail, mortality was 23.5 % in patients with SIRS, 13.1 % in sepsis, 22.1 % in severe sepsis, and 65 % in septic shock. Focus of infection By definition, in SIRS patients no focus and no infection could be diagnosed. Of 168 patients with sepsis, severe sepsis and septic shock, 105 (51 %) had pneumonia, 15 (7.3 %) an infection of the soft tissue, 13 (6.3 %) meningitis, 7 (3.4 %) a urogenital infection, 5 (2.4 %) endocarditis, 4 (1.9 %) peritonitis, 3 (1.5 %) pancreatitis, and 1 (0.5 %) cholangitis. In 8 patients no infectious focus could be found, but blood cultures were positive.
Microbiologic testing
In 102 patients the microbiological testing was positive (Fig. 1., 142 positive cultures) . 50 (47 %) had bacteremia. Most infectious germs were gram positive, predominantly staphylococci or pneumococci (38 % of all cultures).
SIRS
Only a minority of patients with SIRS showed a moderately elevated level of PCT (0.41 3.04 ng/ml) which was significantly different from patients with severe sepsis (P < 0.00 006). AP-II (17.42 1.72 points), fever (37.7 1.88 C), white blood cell count (11,026 2112 mm 3 ), CRP (11.34 2.39 mg/dl) and platelet count (149,769 2145 mm 3 ) did not differ compared to severe sepsis. Neither PCT, nor any of the other parameters differed significantly between SIRS and sepsis.
Severe sepsis vs sepsis
Patients with severe sepsis had significantly higher PCT levels compared to patients with sepsis (6.91 3.87 vs 0.53 2.89 ng/ml; P < 0.000 009). Neither AP-II score (10.26 1.62 points vs 16.09 2.06), nor fever (38.1 0.83 vs 38.34 0.69 C), white blood cell count (13,144 2411 vs 13,156 1625 mm 3 ) or CRP (13.81 2.55 vs 10.48 3.05 mg/dl) differed significantly (Fig. 2.) . The number of thrombocytes was significantly reduced in severe sepsis compared to sepsis (145,191 2288 vs 191,213 1683 mm 3 ; P < 0.03). ROC analysis revealed an optimal cutoff point of > 2.0 ng/ml for the prediction of severe sepsis, with an accuracy of 90 %. The corresponding ROC curve is shown in Fig. 3 . With a cutoff point of 2.0 ng/ml, sensitivity and specificity are estimated as 96 % or 86 %, respectively. With a prevalence of 38 % of severe sepsis/septic shock, the positive predictive value of PCT > 2.0 ng/ml is 81 %, the negative predictive value of PCT £ 2.0 is 97 %. S 150 Fig. 2 Mean values SD of PCT, AP-II and CRP in patients with SIRS (n = N17), sepsis (n = 61), severe sepsis (n = 68), and septic shock (n = 39) at onset of inflammatory symptoms; *P < 0.05, ** = P < 0.001 Septic shock PCT levels were highest in septic shock and differed significantly compared to severe sepsis (12.89 4.39 ng/ml; P < 0.05 vs severe sepsis). CRP and body temperature did not differ significantly between severe sepsis and septic shock (CRP:17.79 3.55 mg/dl; body temperature 38.23 1.03 C). AP-II and cell counts were significantly higher in patients with septic shock than in patients with severe sepsis (AP-II: 29.27 1.35 points, P < 0.00001; white blood cell count: 7160 4901 mm 3 , P < 0.03; platelets: 101,028 2685 mm 3 , P < 0.04). Within the subgroup of patients with severe sepsis/septic shock ROC analysis revealed an optimal cutoff point of 11.6 ng/ml for the prediction of septic shock, with an accuracy of only 60 %. The corresponding ROC curve is shown in Fig. 4 . With a cutoff point of 11.6 ng/ml, sensitivity and specificity are estimated as 53 % or 72 %, respectively. With a prevalence of 41 % for septic shock, the positive predictive value of PCT > 11.6 ng/ml is 52 %, the negative predictive value of PCT £ 11.6 ng/ml is 67 %.
Discussion
In our prospective study PCT was the only parameter tested which demonstrated significant differences between sepsis, severe sepsis, and septic shock on the first day after admission to the ICU or at the onset of inflammatory symptoms. In contrast to PCT the APACHE-II score differed significantly only between severe sepsis and septic shock, as did the white blood cell count and the platelet count.
In a cohort study of 100 post-operative ICU patients [8] PCT levels were 1.3 0.2 ng/ml (SIRS), 2.0 0.0 (sepsis), 8.7 2.5 (severe sepsis), and 38.6 5.9 (septic shock). Another group [9] recently reported median PCT-levels in 78 ICU patients of 0.6 (0±5.3) for SIRS, 3.5 (0.4±6.7) for sepsis, 6.2 (2.2±85) for severe sepsis, and 21.3 (1.2±654) for septic shock. In principal these data are confirmed by our study; the PCT values in SIRS and sepsis, however, were markedly lower in our patients. This may be caused by a different strength of inflammation, which may vary in SIRS patients: the number of positive SIRS criteria is correlated with mortality [11] . Moreover, we investigated non-surgical patients only, whereas in operated patients PCT levels may be increased by the surgical trauma itself [3, 10] . Our data suggest that in patients with even severe infections, but still without remote organ dysfunction, PCT is only moderately increased.
An early diagnosis of severe sepsis, before the results of testing for bacteria, time-consuming laboratory parameters and invasive procedures are available, would certainly help to initiate adequate and timely measures and would possibly improve outcome of patients with septic states. This is especially true in patients compromised by systemic disease (such as lupus erythematodes, vasculitis or diabetes mellitus) or immunosuppressive S 151 therapy, both states which are not accompanied by activation of PCT as has been demonstrated recently [3, 5] .
In a recent study defining the epidemiology of SIRS, sepsis, severe sepsis, and septic shock [11] , 35 % of patients were ªclinicallyº septic and were prescribed antibiotics empirically, but they had no site with a positive culture. Additionally, evaluation of the end-organ dysfunction following the ACCP/SCCM criteria might be difficult in general wards without the possibility of 24 h monitoring. Since there is a stepwise increase in mortality rates in the hierarchy from SIRS to septic shock [11] , it might be important that PCT could help to diagnose and differentiate sepsis and severe sepsis.
PCT is not very helpful in the diagnosis of septic shock which is defined by clinical parameters as the need for vasopressants, and the leuko-and thrombocytopenia. Thus, the AP-II score is a reliable prognostic marker in septic shock. However, it would be interesting to combine PCT levels and the AP-II score, as this might further improve the prognostic value of this score in the presence of septic states.
Further prospective studies of the early phase of sepsis are necessary to define the role of PCT as a prognostic marker in sepsis and severe sepsis, and to investigate its impact on possible therapeutic strategies, such as the early initiation of intensified antibiotic and immunoadditive therapies.
